In this context, our study aimed to evaluate the effectiveness of different GLP-1 RA-based regimens in achieving metabolic control, specifically glycemic control, BWR, and WC improvements in patients with T2DM and various degrees of obesity under routine clinical conditions. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.